Search

Author/Creator Groeneveld, Geert Jan

41. Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties. (16th December 2016)

Authors:
Okkerse, Pieter; Hay, Justin L.; Sitsen, Elske; Dahan, Albert; Klaassen, Erica; Houghton, William; Groeneveld, Geert Jan
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 4(2017:Apr.)
Page Start:
751
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

42. Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti‐hyperalgesic effects, in patients with sciatica. (13th May 2016)

Authors:
Okkerse, Pieter; Hay, Justin L.; Versage, Eve; Tang, Yongqiang; Galluppi, Gerald; Ravina, Bernard; Verma, Ajay; Williams, Leslie; Aycardi, Ernesto; Groeneveld, Geert Jan
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 1(2016:Jul.)
Page Start:
108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

43. Pharmacokinetics and pharmacodynamics of oral mecamylamine – development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation. (February 2017)

Authors:
Alvarez-Jimenez, Ricardo; Baakman, Anne Catrien; Stevens, Jasper; Goulooze, Sebastiaan C; Hart, Ellen P; Rissmann, Robert; van Gerven, Joop MA; Groeneveld, Geert Jan
Journal:
Journal of psychopharmacology
Issue:
Volume 31:Number 2(2017)
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

46. Reversal of mecamylamine‐induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses. (20th February 2018)

Authors:
Alvarez‐Jimenez, Ricardo; Hart, Ellen P.; Prins, Samantha; de Kam, Marieke; van Gerven, Joop M.A.; Cohen, Adam F.; Groeneveld, Geert Jan
Journal:
British journal of clinical pharmacology
Issue:
Volume 84:Number 5(2018:Nov.)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

47. Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients. (April 2022)

Authors:
Thijssen, Eva; den Heijer, Jonas M.; Puibert, David; van Brummelen, Emilie M.J.; Naranda, Tatjana; Groeneveld, Geert Jan
Journal:
Parkinsonism & related disorders
Issue:
Volume 97(2022)
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

48. Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1‐acetylcholine receptor agonist: A randomized cross‐over trial. Issue 11 (8th May 2021)

Authors:
Bakker, Charlotte; Prins, Samantha; Liptrot, Jan; Hart, Ellen P.; Klaassen, Erica S.; Brown, Giles A.; Brown, Alastair; Congreve, Miles; Weir, Malcolm; Marshall, Fiona H.; Stevens, Jasper; Cross, David M.; Tasker, Tim; Nathan, Pradeep J.; Groeneveld, Geert Jan
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 11(2021)
Page Start:
4439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

49. Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study. Issue 5 (29th December 2020)

Authors:
van Diemen, Marcus P.J.; Hart, Ellen P.; Abbruscato, Anthony; Mead, Liz; van Beelen, Ilse; Bergheanu, Sandrin C.; Hameeteman, Pieter W.; Coppen, Emma; Winder, Jessica Y.; Moerland, Matthijs; Kan, Hermien; van der Grond, Jeroen; Webb, Andrew; Roos, Raymund A.C.; Groeneveld, Geert Jan
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 5(2021)
Page Start:
2290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

50. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib studies in healthy subjects and patients. Issue 8 (1st June 2022)

Authors:
Vissers, Maurits F. J. M.; Heuberger, Jules A. A. C.; Groeneveld, Geert Jan; Oude Nijhuis, Jerome; De Deyn, Peter Paul; Hadi, Salah; Harris, Jeffrey; Tsai, Richard M.; Cruz‐Herranz, Andres; Huang, Fen; Tong, Vincent; Erickson, Rebecca; Zhu, Yuda; Scearce‐Levie, Kimberly; Hsiao‐Nakamoto, Jennifer;...
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 8(2022)
Page Start:
2010
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗